Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 375Active not recruiting 187Completed 96Not yet recruiting 75Terminated 26Suspended 17Enrolling by invitation 11Withdrawn 5Available 5No longer available 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 17Lymphoid 16Thoracic 13Other hematologic neoplasm 10Gastrointestinal 10Breast 6Tumor-Agnostic 5Plasma cell 5CNS 5Other solid neoplasm 4Head & Neck 4Dermatologic 4Gynecologic 3Sarcoma 1Myeloid 1Classical hematology 1

Conditions

Glioblastoma 2Spinal Cord Neoplasms 1Oligodendroglioma 1Glioma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Radiation 3Temozolomide 2vocimagene amiretrorepvec 1irinotecan sucrosofate 1Radiotherapy 1Irinotecan 1Diet 1DNA 1Cysteine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × CNS × 90 days × Clear all
NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

SynerGene Therapeutics, Inc.

Phase EARLY_PHASE1 Withdrawn
CNS

Central Nervous System Neoplasms

NCT04105374 2026-05-07

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

NRG Oncology

Phase 2/3 Withdrawn
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT04084431 2026-05-05

RECARE

University Hospital Heidelberg

Phase NA Withdrawn
CNS

Brain Neoplasms

NCT07553520 2026-04-28

Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients

UNC Lineberger Comprehensive Cancer Center

Phase NA Withdrawn
CNS

Glioblastoma, Glioma

NCT04533919 2026-04-06

Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

M.D. Anderson Cancer Center

Withdrawn
CNS

Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡